{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:07:08Z","timestamp":1769119628005,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heart failure (HF) is a major global challenge, emphasised by its designation as the leading cause of hospitalisation in those aged 65 and above. Approximately half of all patients with HF have concurrent iron deficiency (ID) regardless of anaemia status. In HF, iron deficiency is independently associated with higher rates of hospitalisation and death, lower exercise capacity, and poorer quality-of-life than in patients without iron deficiency. With such consequences, several studies have investigated whether correcting ID can improve HF outcomes.<\/jats:p>\n                <jats:p>Main body.<\/jats:p>\n                <jats:p>As of 1st June 2021, seven randomised controlled trials have explored the use of intravenous (IV) iron in patients with HF and ID, along with various meta-analyses including an individual patient data meta-analysis, all of which are discussed in this review. IV iron was well tolerated, with a comparable frequency of adverse events to placebo. In the context of heart failure with reduced ejection fraction (HFrEF), IV iron reduces the risk of hospitalisation for HF, and improves New York Heart Association (NYHA) functional class, quality-of-life, and exercise capacity (as measured by 6-min walk test (6MWT)) distance and peak oxygen consumption. However, the effect of IV iron on mortality is uncertain. Finally, the evidence for IV iron in patients with acute decompensated heart failure, or heart failure with preserved ejection fraction (HFpEF) is limited.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>IV iron improves some outcomes in patients with HFrEF and ID. Patients with HFrEF should be screened for ID, defined as ferritin\u2009&lt;\u2009100\u00a0\u00b5g\/L, or ferritin 100\u2013299\u00a0\u00b5g\/L if transferrin saturation\u2009&lt;\u200920%. If ID is found, IV iron should be considered, although causes of ID other than HF must not be overlooked.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s43044-021-00211-3","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T20:04:40Z","timestamp":1632686680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Iron replacement therapy in heart failure: a literature review"],"prefix":"10.1186","volume":"73","author":[{"given":"Hassan","family":"Ismahel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeen","family":"Ismahel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"key":"211_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/heart.83.5.596","volume":"83","author":"JJ McMurray","year":"2000","unstructured":"McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83:596\u2013602","journal-title":"Heart"},{"issue":"4","key":"211_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.11909\/j.issn.1671-5411.2014.04.008","volume":"11","author":"N Azad","year":"2014","unstructured":"Azad N, Lemay G (2014) Management of chronic heart failure in the older population. J Geriatr Cardiol. 11(4):329\u2013337. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2014.04.008","journal-title":"J Geriatr Cardiol."},{"key":"211_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ejhf.823","volume":"20","author":"SD Anker","year":"2018","unstructured":"Anker SD, Kirwan BA, van Veldhuisen DJ et al (2018) Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail 20:125\u2013133. https:\/\/doi.org\/10.1002\/ejhf.823","journal-title":"Eur J Heart Fail"},{"key":"211_CR4","first-page":"e6","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL et al (2013) Heart disease and stroke statistics \u2013 2013 update: a report from the American Heart Association. Circulation 127:e6\u2013e245","journal-title":"Circulation"},{"key":"211_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","volume":"15","author":"AP Maggioni","year":"2013","unstructured":"Maggioni AP, Dahlstrom U, Filippatos G et al (2013) EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 15:808\u2013817","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"211_CR6","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis GD, Malhotra R, Hernandez AF et al (2017) Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA 317(19):1958\u20131966. https:\/\/doi.org\/10.1001\/jama.2017.5427","journal-title":"JAMA"},{"issue":"3","key":"211_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.15420\/cfr.2019.9.2","volume":"5","author":"N Ebner","year":"2019","unstructured":"Ebner N, von Haehling S (2019) Why is iron deficiency recognised as an important comorbidity in heart failure? Card Fail Rev. 5(3):173\u2013175. https:\/\/doi.org\/10.15420\/cfr.2019.9.2","journal-title":"Card Fail Rev."},{"issue":"1","key":"211_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchf.2018.07.015","volume":"7","author":"S von Haehling","year":"2019","unstructured":"von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD (2019) Iron deficiency in heart failure: an overview. JACC Heart Fail 7(1):36\u201346. https:\/\/doi.org\/10.1016\/j.jchf.2018.07.015","journal-title":"JACC Heart Fail"},{"issue":"1","key":"211_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02829934","volume":"1","author":"G Cairo","year":"2006","unstructured":"Cairo G, Bernuzzi F, Recalcati S (2006) A precious metal: iron, an essential nutrient for all cells. Genes Nutr 1(1):25\u201339. https:\/\/doi.org\/10.1007\/BF02829934","journal-title":"Genes Nutr"},{"issue":"2","key":"211_CR10","first-page":"51","volume":"37","author":"DF Wallace","year":"2016","unstructured":"Wallace DF (2016) The regulation of iron absorption and homeostasis. Clin Biochem Rev 37(2):51\u201362","journal-title":"Clin Biochem Rev"},{"issue":"1","key":"211_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.15420\/cfr.2018:6:2","volume":"4","author":"IR Mordi","year":"2018","unstructured":"Mordi IR, Tee A, Lang CC (2018) Iron therapy in heart failure: ready for primetime? Card Fail Rev. 4(1):28\u201332. https:\/\/doi.org\/10.15420\/cfr.2018:6:2","journal-title":"Card Fail Rev."},{"issue":"26","key":"211_CR12","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJM199912233412607","volume":"341","author":"NC Andrews","year":"1999","unstructured":"Andrews NC (1999) Disorders of iron metabolism [published correction appears in N Engl J Med 2000 Feb 3;342(5):364]. N Engl J Med 341(26):1986\u20131995. https:\/\/doi.org\/10.1056\/NEJM199912233412607","journal-title":"N Engl J Med"},{"issue":"Pt 20","key":"211_CR13","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1242\/jeb.01172","volume":"207","author":"GA Ordway","year":"2004","unstructured":"Ordway GA, Garry DJ (2004) Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol 207(Pt 20):3441\u20133446. https:\/\/doi.org\/10.1242\/jeb.01172","journal-title":"J Exp Biol"},{"issue":"2","key":"211_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1152\/ajpgi.00412.2005","volume":"290","author":"T Ganz","year":"2006","unstructured":"Ganz T, Nemeth E (2006) Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 290(2):199\u2013203. https:\/\/doi.org\/10.1152\/ajpgi.00412.2005","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"2","key":"211_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MOG.0b013e32831ef1f7","volume":"25","author":"GJ Anderson","year":"2009","unstructured":"Anderson GJ, Frazer DM, McLaren GD (2009) Iron absorption and metabolism. Curr Opin Gastroenterol 25(2):129\u2013135. https:\/\/doi.org\/10.1097\/MOG.0b013e32831ef1f7","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"211_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000496822","volume":"142","author":"O Zusman","year":"2019","unstructured":"Zusman O, Itzhaki Ben Zadok O, Gafter-Gvili A (2019) Management of Iron Deficiency in Heart Failure. Acta Haematol. 142(1):51\u201356. https:\/\/doi.org\/10.1159\/000496822","journal-title":"Acta Haematol."},{"issue":"4","key":"211_CR17","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ehf2.12490","volume":"6","author":"C Adlbrecht","year":"2019","unstructured":"Adlbrecht C (2019) Intravenous iron therapy for patients with heart failure: expanding body of evidence. ESC Heart Fail 6(4):581\u2013583. https:\/\/doi.org\/10.1002\/ehf2.12490","journal-title":"ESC Heart Fail"},{"issue":"5704","key":"211_CR18","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J et al (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090\u20132093. https:\/\/doi.org\/10.1126\/science.1104742","journal-title":"Science"},{"issue":"1","key":"211_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","volume":"138","author":"IS Anand","year":"2018","unstructured":"Anand IS, Gupta P (2018) Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation 138(1):80\u201398. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.030099","journal-title":"Circulation"},{"issue":"2","key":"211_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","volume":"11","author":"N Grote Beverborg","year":"2018","unstructured":"Grote Beverborg N, Klip IT, Meijers WC et al (2018) Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients. Circ Heart Fail 11(2):e004519. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004519","journal-title":"Circ Heart Fail"},{"issue":"5","key":"211_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jacc.2011.01.059","volume":"58","author":"MT Maeder","year":"2011","unstructured":"Maeder MT, Khammy O, dos Remedios C, Kaye DM (2011) Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol 58(5):474\u2013480. https:\/\/doi.org\/10.1016\/j.jacc.2011.01.059","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"211_CR22","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ejhf.1154","volume":"20","author":"MF Hoes","year":"2018","unstructured":"Hoes MF, Grote Beverborg N, Kijlstra JD et al (2018) Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function. Eur J Heart Fail 20(5):910\u2013919. https:\/\/doi.org\/10.1002\/ejhf.1154","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"211_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky V, Petrak J, Mracek T et al (2017) Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail 19(4):522\u2013530. https:\/\/doi.org\/10.1002\/ejhf.640","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"211_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jacc.2007.09.036","volume":"51","author":"DO Okonko","year":"2008","unstructured":"Okonko DO, Grzeslo A, Witkowski T et al (2008) Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 51(2):103\u2013112. https:\/\/doi.org\/10.1016\/j.jacc.2007.09.036","journal-title":"J Am Coll Cardiol"},{"key":"211_CR25","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/eurheartj\/ehs224","volume":"34","author":"EA Jankowska","year":"2013","unstructured":"Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski PP (2013) Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 34:816","journal-title":"Eur Heart J"},{"key":"211_CR26","doi-asserted-by":"publisher","unstructured":"Graham FJ, Pellicori P, Ford I, Petrie MC, Kalra PR, Cleland JGF. Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials [published online ahead of print, 2021 Mar 23]. Clin Res Cardiol. 2021. https:\/\/doi.org\/10.1007\/s00392-021-01837-8","DOI":"10.1007\/s00392-021-01837-8"},{"key":"211_CR27","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jacc.2011.04.040","volume":"58","author":"DO Okonko","year":"2011","unstructured":"Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA (2011) Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 58:1241\u20131251. https:\/\/doi.org\/10.1016\/j.jacc.2011.04.040","journal-title":"J Am Coll Cardiol"},{"key":"211_CR28","doi-asserted-by":"publisher","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure [published correction appears in Eur Heart J. 2011 May;32(9):1054].\u00a0Eur Heart J. 2010;31(15):1872\u20131880. https:\/\/doi.org\/10.1093\/eurheartj\/ehq158","DOI":"10.1093\/eurheartj\/ehq158"},{"issue":"11","key":"211_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cardfail.2011.08.003","volume":"17","author":"EA Jankowska","year":"2011","unstructured":"Jankowska EA, Rozentryt P, Witkowska A et al (2011) Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 17(11):899\u2013906. https:\/\/doi.org\/10.1016\/j.cardfail.2011.08.003","journal-title":"J Card Fail"},{"issue":"3","key":"211_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.rec.2015.08.018","volume":"69","author":"C Enjuanes","year":"2016","unstructured":"Enjuanes C, Bruguera J, Grau M et al (2016) Iron status in chronic heart failure: impact on symptoms, functional class and submaximal exercise capacity. Rev Esp Cardiol (Engl Ed) 69(3):247\u2013255. https:\/\/doi.org\/10.1016\/j.rec.2015.08.018","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"2","key":"211_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijcard.2014.03.169","volume":"174","author":"C Enjuanes","year":"2014","unstructured":"Enjuanes C, Klip IT, Bruguera J et al (2014) Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study. Int J Cardiol 174(2):268\u2013275. https:\/\/doi.org\/10.1016\/j.ijcard.2014.03.169","journal-title":"Int J Cardiol"},{"issue":"10","key":"211_CR32","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/eurjhf\/hft083","volume":"15","author":"J Com\u00edn-Colet","year":"2013","unstructured":"Com\u00edn-Colet J, Enjuanes C, Gonz\u00e1lez G et al (2013) Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail 15(10):1164\u20131172. https:\/\/doi.org\/10.1093\/eurjhf\/hft083","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"211_CR33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","volume":"165","author":"IT Klip","year":"2013","unstructured":"Klip IT, Comin-Colet J, Voors AA et al (2013) Iron deficiency in chronic heart failure: an international pooled analysis. Am Heart J 165(4):575-582.e3. https:\/\/doi.org\/10.1016\/j.ahj.2013.01.017","journal-title":"Am Heart J"},{"issue":"17","key":"211_CR34","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.jacc.2007.07.029","volume":"50","author":"JE Toblli","year":"2007","unstructured":"Toblli JE, Lombra\u00f1a A, Duarte P, Di Gennaro F (2007) Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 50(17):1657\u20131665. https:\/\/doi.org\/10.1016\/j.jacc.2007.07.029","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"211_CR35","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361(25):2436\u20132448. https:\/\/doi.org\/10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"issue":"11","key":"211_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J et al (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J 36(11):657\u2013668. https:\/\/doi.org\/10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"issue":"15","key":"211_CR37","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ van Veldhuisen","year":"2017","unstructured":"van Veldhuisen DJ, Ponikowski P, van der Meer P et al (2017) Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation 136(15):1374\u20131383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.027497","journal-title":"Circulation"},{"issue":"2","key":"211_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/ehf2.12250","volume":"5","author":"TJ Yeo","year":"2018","unstructured":"Yeo TJ, Yeo PSD, Hadi FA et al (2018) Single-dose intravenous iron in Southeast Asian heart failure patients: a pilot randomized placebo-controlled study (PRACTICE-ASIA-HF). ESC Heart Fail 5(2):344\u2013353. https:\/\/doi.org\/10.1002\/ehf2.12250","journal-title":"ESC Heart Fail"},{"issue":"10266","key":"211_CR39","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski P, Kirwan BA, Anker SD et al (2020) Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 396(10266):1895\u20131904. https:\/\/doi.org\/10.1016\/S0140-6736(20)32339-4","journal-title":"Lancet"},{"issue":"6","key":"211_CR40","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1002\/ehf2.13146","volume":"7","author":"MS Khan","year":"2020","unstructured":"Khan MS, Usman MS, von Haehling S, Doehner W, Stewart Coats AJ (2020) Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis. ESC Heart Fail 7(6):3392\u20133400. https:\/\/doi.org\/10.1002\/ehf2.13146","journal-title":"ESC Heart Fail"},{"issue":"7","key":"211_CR41","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/ejhf.473","volume":"18","author":"EA Jankowska","year":"2016","unstructured":"Jankowska EA, Tkaczyszyn M, Suchocki T et al (2016) Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail 18(7):786\u2013795. https:\/\/doi.org\/10.1002\/ejhf.473","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"211_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/eurjhf\/hfs017","volume":"14","author":"T Avni","year":"2012","unstructured":"Avni T, Leibovici L, Gafter-Gvili A (2012) Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 14(4):423\u2013429. https:\/\/doi.org\/10.1093\/eurjhf\/hfs017","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"211_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cjca.2015.06.009","volume":"32","author":"C Qian","year":"2016","unstructured":"Qian C, Wei B, Ding J, Wu H, Wang Y (2016) The efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a systematic review and meta-analysis. Can J Cardiol 32(2):151\u2013159. https:\/\/doi.org\/10.1016\/j.cjca.2015.06.009","journal-title":"Can J Cardiol"},{"key":"211_CR44","doi-asserted-by":"publisher","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC [published correction appears in Eur Heart J. 2016 Dec 30;:]. Eur Heart J. 2016;37(27):2129\u20132200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"211_CR45","unstructured":"Kocyigit D, G\u00fcrses KM. Iron deficiency and its treatment in heart failure: indications and effect on prognosis. ESC E-Journal of Cardiology Practice 2016; 14(30): https:\/\/www.escardio.org\/Journals\/E-Journal-of-Cardiology-Practice\/Volume-14\/Iron-deficiency-and-its-treatment-in-heart-failure-indications-and-effect-on-prognosis. Accessed 5 June 2021."},{"key":"211_CR46","unstructured":"Scottish Intercollegiate Guidelines Network. SIGN 147: Management of chronic heart failure. 2016. Available at: www.sign.ac.uk\/assets\/sign147.pdf. Accessed 5 June 2021."},{"issue":"6","key":"211_CR47","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart failure Society of America. J Am Coll Cardiol 70(6):776\u2013803. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.025","journal-title":"J Am Coll Cardiol"},{"key":"211_CR48","unstructured":"National Institute for Health and Care Excellence. Chronic heart failure in adults Diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng106\/evidence\/full-guideline-pdf-6538850029. Accessed 5 June 2021."},{"key":"211_CR49","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijcard.2017.04.110","volume":"243","author":"P Moliner","year":"2017","unstructured":"Moliner P, Jankowska EA, van Veldhuisen DJ et al (2017) Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure. Int J Cardiol 243:360\u2013366. https:\/\/doi.org\/10.1016\/j.ijcard.2017.04.110","journal-title":"Int J Cardiol"},{"key":"211_CR50","unstructured":"Doehner W, von Haeling S, Ebner N (2017, August 1 \u2013 2021, July). Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction (FAIR-HFpEF). Identifier NCT03074591. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03074591"},{"key":"211_CR51","doi-asserted-by":"crossref","unstructured":"Karla P, Thomson E (2016, August \u2013 2022, March). Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN (IRONMAN). Identifier NCT02642562. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02642562","DOI":"10.1186\/ISRCTN16403302"},{"key":"211_CR52","unstructured":"Karakas M, Anker S (2017, February 7 \u2013 2021, December). Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality (FAIR-HF2). Identifier NCT03036462. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03036462"},{"issue":"5","key":"211_CR53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.008100","volume":"14","author":"RJ Mentz","year":"2021","unstructured":"Mentz RJ, Ambrosy AP, Ezekowitz JA et al (2021) Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design. Circ Heart Fail 14(5):e008100. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.008100","journal-title":"Circ Heart Fail"},{"issue":"1","key":"211_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mayocp.2014.10.007","volume":"90","author":"T Avni","year":"2015","unstructured":"Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A (2015) The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc 90(1):12\u201323. https:\/\/doi.org\/10.1016\/j.mayocp.2014.10.007","journal-title":"Mayo Clin Proc"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-021-00211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-021-00211-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-021-00211-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T20:20:35Z","timestamp":1632687635000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-021-00211-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["211"],"URL":"https:\/\/doi.org\/10.1186\/s43044-021-00211-3","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}